Page last updated: 2024-12-08

uvinul t 150

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Uvinul T 150: RN given refers to cpd with unknown MF; no further information available 5/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159201
CHEMBL ID4462531
SCHEMBL ID62195
MeSH IDM0164889

Synonyms (51)

Synonym
octyl triazone
2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate
NCGC00183599-01
88122-99-0
unii-xqn8r9sak4
uvinul t 150
uvasorb et
xqn8r9sak4 ,
ec 402-070-1
ethylhexyl triazone ,
uvinul t150
benzoic acid, 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tris-, tris(2-ethylhexyl) ester
tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
uvinul-t-150
116244-12-3
FT-0688084
octyl triazone [who-dd]
ethylhexyl triazone [inci]
2,4,6-trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine
ethylhexyl triazone [mi]
octil triazone
ethylhexyl triazone [usp-rs]
SCHEMBL62195
Q-201502
tris(2-ethylhexyl) 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate
c48h66n6o6
ethylhexyl triazone, analytical standard
ethylhexyl triazone, united states pharmacopeia (usp) reference standard
AKOS030228640
CHEMBL4462531
JGUMTYWKIBJSTN-UHFFFAOYSA-N
uvt-150
2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine
DS-3287
DTXSID90868994
DB15469
Q2455834
HY-109655
CS-0033785
tris(2-ethylhexyl) 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate
E1312
4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoic acid tris(2-ethylhexyl) ester
uvt-150; uvinul t 150 pound>>ethylhexyl triazone pound>>uv-t-150
BCP11409
mfcd09753106
AMY42004
T73032
benzoic acid, 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tris-,1,1',1''-tris(2-ethylhexyl) ester
tris(2-ethylhexyl)4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate
SY077954
tris(2-ethylhexyl) 4,4 inverted exclamation mark ,4 inverted exclamation mark inverted exclamation mark -[(1,3,5-triazine-2,4,6-triyl)tris(azanediyl)]tribenzoate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1611502Antioxidant activity assessed as DPPH free radical scavenging activity at 200 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611507Photoprotection activity against UV radiation2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611506Thermal stability of compound in DMSO/methanol assessed as mass loss by UV spectroscopic method2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611505Thermal stability of compound in DMSO/methanol assessed as decomposition temperature by UV spectroscopic method2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611501Antioxidant activity assessed as DPPH free radical scavenging activity at 300 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611503Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611504Thermal stability of compound in DMSO/methanol assessed as onset temperature by UV spectroscopic method2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611499Photoprotection activity against UV radiation assessed as ratio of UVA to UVB2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1611500Antioxidant activity assessed as DPPH free radical scavenging activity at 400 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's6 (50.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.95 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index67.74 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]